Trial Profile
Investigation of Cerebrospinal Fluid (CSF) Pharmacokinetics of Ondansetron
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jun 2020
Price :
$35
*
At a glance
- Drugs Ondansetron (Primary)
- Indications Neuropathic pain
- Focus Pharmacokinetics
- 04 Jun 2020 Results published in the British Journal of Clinical Pharmacology
- 19 Apr 2017 Status changed from recruiting to completed.
- 28 Sep 2016 New trial record